pUltra-puro-RTTA3 Citations (1)
Originally described in: pUltra plasmidsUnpublished
Articles Citing pUltra-puro-RTTA3
| Articles |
|---|
| CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Joung J, Kirchgatterer PC, Singh A, Cho JH, Nety SP, Larson RC, Macrae RK, Deasy R, Tseng YY, Maus MV, Zhang F. Nat Commun. 2022 Mar 25;13(1):1606. doi: 10.1038/s41467-022-29205-8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.